Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Resistant Hypertension
NCT02232880Phase 2Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2014
- Primary completion
- Jun 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in resistant hypertension (RH), sponsored by Vanderbilt University Medical Center. Started Aug 2014; status: terminated.
02
Drugs
abatacept
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT02232880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02232880.